Case Report
Published on 25 Jan 2022
Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report
- 4,138 views
- 13 citations
Case Report
Published on 25 Jan 2022
Original Research
Published on 25 Jan 2022
Systematic Review
Published on 25 Jan 2022
Review
Published on 25 Jan 2022
Original Research
Published on 25 Jan 2022
Original Research
Published on 25 Jan 2022
Review
Published on 25 Jan 2022
Review
Published on 25 Jan 2022
Original Research
Published on 25 Jan 2022
Original Research
Published on 25 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Systematic Review
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022